Entering text into the input field will update the search result below

Today's healthcare analyst action

Dec. 19, 2016 4:07 PM ETCidara Therapeutics, Inc. (CDTX) StockBMY, MRK, ACORQ, DXCM, SCTL, CDTXBy: Douglas W. House, SA News Editor
  • H.C. Wainwright initiates coverage on Cidara Therapeutics (NASDAQ:CDTX) with a Buy rating and $25 (136% upside) price target.
  • Janney Capital initiates coverage on Acorda Therapeutics (NASDAQ:ACOR) with a Neutral rating and $23 (23% upside) price target.
  • Piper Jaffray initiates coverage on Recro Pharma (NASDAQ:REPH) with an Overweight rating and $12 (68% upside) price target.
  • Oppenheimer upgrades DexCom (NASDAQ:DXCM) to Outperform from Perform.
  • Jefferies upgrades Bristol-Myers Squibb (NYSE:BMY) to Buy from Hold.
  • Jefferies downgrades Merck (NYSE:MRK) to Underperform from Hold.

Recommended For You

More Trending News

About CDTX Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
CDTX--
Cidara Therapeutics, Inc.